Cancer Immunotherapy Downloads
-
CellGenix - Model GMP SCGM - Growth Medium Serum-Free Stem Cell - Brochure
CellGenix GMP SCGM is an optimized, xeno-free medium used for the serum-free expansion of low numbers of isolated human hematopoietic stem and progenitor cells (HSCs/CD34+ cells). In addition, our SCGM is proved to be highly efficient for the expansion and cultivation of human natural killer cells (NK cells) and human cytokine induced killer cells (CIK cells). ...
-
Highplex - Version FL - Cell-Based Analysis Module - Brochure
Indica Labs’ Highplex FL module allows for simultaneous analysis of an unlimited number of fluorescent markers in any cellular compartment – nucleus, cytoplasm, and/or membrane. With the option to define specific cell phenotypes according to marker positivity, this module is ideally suited for applications in immuno-oncology where multiple markers are required to characterize ...
-
BriaCell - Corporate Highlights - Datasheet
BriaCell Therapeutics Corp. is a clinical stage immunotherapy company developing treatments that boost the ability of the body’s own cancer-fighting cells to destroy cancerous ...
-
BriaCell Therapeutics - Presentation
Focusing initially on breast cancer, BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) is dedicated to enhancing the lives of people with cancer with limited therapy options by developing novel immunotherapies to fight cancer. Immunotherapies have become the forefront of the cancer treatments because they use the body’s immune system to destroy cancer cells, offer the potential ...
-
Biomed - Models Onko BCG 50 and Onko BCG 100 - Brochure
Onko BCG 100. Powder and solvent for suspension for intravesical use. BCG ad immunocurationem. BCG for immunotherapy. ...
-
Model Anti-HLA-DR APC-Cyanine7 - Mouse Monoclonal Antibody - Technical Datasheet
The clone L243, a mouse monoclonal antibody, recognizes a heterodimeric cell surface glycoprotein comprised of a 36 kD α (heavy) chain and a 27 kD β (light) chain known as human HLA-DR antigen. HLA-DR is widely expressed on monocytes, macrophages, activated T and B lymphocytes, activated natural killer (NK) cells, and human progenitor cells. HLA-DR is also present on thymic epithelium, ...
-
Cypre - 3D Tumor Model Platform - Brochure
Cypre’s 3D Tumor Models combine the tumor, stromal and immune compartments in a high throughput format to screen targeted drugs and immunotherapy. In 2021, we partnered with Charles River to offer our 3D Tumor Models for drug discovery and preclinical screening services. ...
By Cypre, Inc.
-
Exscientia - Model EXS21546 - Peripherally-Restricted and Selective Antagonist Drug - Brochure
EXS21546 is our peripherally-restricted and selective antagonist of the Adenosine A2a Receptor. It is designed for anti-cancer immunotherapy, combatting adenosine related immunosuppressive effects, through T-cell ...
By Exscientia
-
OncoFOLLOW Brochure
OncoFOLLOW: The first personalised liquid biopsy in the market. Monitor the progression and detect lack of response. OncoFOLLOW is a test based on the analysis of circulating tumor DNA in blood. It is used to monitor the progression of the tumor (burden of the disease) and to detect lack of response or resistance to treatment as soon as it appears. This assay is customised for each patient, as it ...
By OncoDNA S.A.
-
MHC Tetramer for Cancer
MHC tetramers allow for ex vivo selection and proliferation of T-cells specific to tumor-related antigens, which can then be reintroduced to augment the immune system. Cancer immunotherapy would be largely influenced by this ...
-
Diamyd Medical AB Company Brochure
Diamyd Medical is a clinical-stage diabetes company active in the field of pharmaceutical development. We develop two novel disease-modifying drugs: the antigenspecific immunotherapy Diamyd and the oral regenerative and immunomodulatory therapeutic Remygen. Diamyd and Remygen are evaluated in ongoing clinical studies. The therapies target the underlying causes of diabetes, dysfunction and loss of ...
-
Transgene - Model 5 - Oncolytic Viruses - Brochure
Collaboration with AstraZeneca. Transgeneand AstraZeneca enterinto a collaboration and exclusive license option agreement for innovative Invir.IO based armedoncolytic ...
By Transgene
-
Immunoscore for Colon Cancer Patients - Brochure
To date, the classification of cancers has been based solely on the phenotypic and genotypic characteristics of tumor cells. A new paradigm, scientifically well established and recommended by WHO guidelines, relies on the introduction of the immune response as a new prognostic parameter to predict and refine the clinical outcomes of cancer patients. Maximize patient survival rates with an ...
By Veracyte
-
Brightplext - Model IHC - Multiplex Cell Technology - Brochure
HalioDx has developed advanced, reliable and customizable technologies to help immunotherapies developers in rationalizing and accelerating the pace of clinical programs from early phases to ...
By Veracyte
-
MedGenome - Model OncoPeptTUME - Immunotherapy Drugs - Brochure
OncoPeptTUME — A novel in-silico approach to model the tumor microenvironment and predict treatment efficacy and long-term survival benefits for immunotherapy applications. Cancer immunotherapy is now established as a major therapeutic modality. Cancer immunotherapy drugs elicit their anti-tumor immune response in a subset of the treated patients by activating CD8 T-cells and provide ...
-
Indivumed - Immuno-Oncology Service - Brochure
Cancer immunology, or “immuno-oncology,” is a growing field of research that aims to discover innovative cancer immunotherapies to treat and impede the progression of the disease. Understanding how cancer evades the immune system is the basis of immuno-oncology. With Indivumed’s scientific support you can, for example, identify the different types of immune cells and their ...
-
Biocon Fact Sheet
Biocon Limited, publicly listed in 2004, (BSE code: 532523, NSE Id: BIOCON, ISIN Id: INE376G01013) is an innovation-led global biopharmaceuticals company committed to enhance ordable access to complex therapies for chronic conditions like diabetes, oncology and immunology. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key ...
By Biocon
-
Elabscience - Model FITC - [17A2]- E-AB-F1013C - Anti-Mouse CD3 Antibody- Brochure
CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell ...
By Elabscience
-
Promega - Model 4-1BB - Immune Checkpoint Bioassays Cells Brochure
4-1BB (CD137/TNFRSF9), a member of the tumor necrosis factor receptor superfamily, is an inducible co-stimulatory receptor expressed on T cells, natural killer (NK) cells and innate immune cell populations. When present on the cell surface, 4-1BB interacts with 4-1BB ligand (4-1BBL) and induces subsequent cell proliferation and production of interferon gamma (IFNγ) and interleukin-2 (IL-2), ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you